Not sure what that is in the field of science other than I guess the stench of inuendo. Nobody on this board, including a guy who has "dumped" all his shares all the while criticizing the company as the price fell, has any knowledge of why LEO is turning the trials over to LFB.
I did ask Rustyboy a couple of weeks ago about this and he said he had been told by management that it had something to do with LEO being under some charitable trust or some such. I can tell you and I feel certain both biopearl and MBT would feel the same way that the pathophysiology is certainly compatable with AT possibly working in DIC and that the KS subset AT without heparin is reasonably compelling. Thats about the best you can do when it comes to these things.